Article ; Online: Recombinant ling zhi-8 enhances Tregs function to restore glycemic control in streptozocin-induced diabetic rats.
The Journal of pharmacy and pharmacology
2020 Volume 72, Issue 12, Page(s) 1946–1955
Abstract: Objectives: To explore the effect of recombinant LZ-8 (rLZ-8) on streptozocin (STZ)-induced diabetic rats and further illustrate its underlying mechanism.: Methods: Rats were intraperitoneally injected with single-dose STZ 50 mg/kg for induction of ... ...
Abstract | Objectives: To explore the effect of recombinant LZ-8 (rLZ-8) on streptozocin (STZ)-induced diabetic rats and further illustrate its underlying mechanism. Methods: Rats were intraperitoneally injected with single-dose STZ 50 mg/kg for induction of type 1 diabetes (T1D), and then, the diabetic rats were treated with rLZ-8 for 3 months. The clinical symptoms, fasting blood glucose, insulin, cytokines, histopathology, flow cytometry and immunofluorescence were used to evaluate the therapeutic effect and underlying mechanism of rLZ-8 on alleviating diabetes mellitus (DM). Key findings: Treatment with rLZ-8 obviously alleviated the clinical symptoms of T1D and dose-dependently reduced the levels of blood glucose, blood lipid and haemoglobin A1c (HbA1c) in diabetic rat model. Meanwhile, rLZ-8 markedly increased insulin secretion and protected against STZ-induced pancreatic tissue injury. Additionally, rLZ-8 dramatically inhibited the levels of TNF-α and IL-1β, and obviously increased the level of IL-10 in serum and pancreas. Further investigation indicated that rLZ-8 treatment significantly increased the number of regulatory T cells (Tregs) and up-regulated the expression of Foxp3 to restore balance between anti-inflammatory and inflammatory cytokines. Conclusions: These data suggest that rLZ-8 can antagonize STZ-induced T1D, and its mechanism may be related to inhibit inflammation and enhance Tregs generation. |
---|---|
MeSH term(s) | Animals ; Anti-Inflammatory Agents/pharmacology ; Biomarkers/blood ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Cytokines/blood ; Diabetes Mellitus, Experimental/blood ; Diabetes Mellitus, Experimental/chemically induced ; Diabetes Mellitus, Experimental/drug therapy ; Diabetes Mellitus, Experimental/immunology ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/chemically induced ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/immunology ; Fungal Proteins/pharmacology ; Glycemic Control ; Hypoglycemic Agents/pharmacology ; Inflammation Mediators/blood ; Male ; Rats, Sprague-Dawley ; Recombinant Proteins/pharmacology ; Streptozocin ; T-Lymphocytes, Regulatory/drug effects ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/metabolism |
Chemical Substances | Anti-Inflammatory Agents ; Biomarkers ; Blood Glucose ; Cytokines ; Fungal Proteins ; Hypoglycemic Agents ; Inflammation Mediators ; Recombinant Proteins ; LZ-8 protein, Ganoderma lucidum (127187-71-7) ; Streptozocin (5W494URQ81) |
Language | English |
Publishing date | 2020-08-17 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 3107-0 |
ISSN | 2042-7158 ; 0022-3573 ; 0373-1022 |
ISSN (online) | 2042-7158 |
ISSN | 0022-3573 ; 0373-1022 |
DOI | 10.1111/jphp.13360 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uf I Zs.149: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.